UBS Group Portfolio holdings
UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Comcast
CMCSA
|
+$488M |
| 2 |
NXP Semiconductors
NXPI
|
+$484M |
| 3 |
JPMorgan Chase
JPM
|
+$429M |
| 4 |
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
|
+$426M |
| 5 |
iShares Core MSCI EAFE ETF
IEFA
|
+$322M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UBS Group
UBS
|
+$755M |
| 2 |
Apple
AAPL
|
+$563M |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$419M |
| 4 |
PepsiCo
PEP
|
+$387M |
| 5 |
Meta Platforms (Facebook)
META
|
+$386M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.14% |
| 2 | Financials | 7.54% |
| 3 | Healthcare | 5.64% |
| 4 | Industrials | 5.09% |
| 5 | Consumer Discretionary | 4.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3101
Core Laboratories
CLB
$521M
| $2.04M | ﹤0.01% |
18,842
+4,629
| +33% | +$512K |
|
|
EPZM
3102
DELISTED
Epizyme, Inc
EPZM
| $2.04M | ﹤0.01% |
114,740
+102,620
| +847% | +$1.73M |
|
3103
PUT
Ally Financial
ALLY
$13.3B
| $2.04M | ﹤0.01% |
75,000
| – | – |
|
3104
Keysight
KEYS
$58.3B
| $2.04M | ﹤0.01% |
38,868
-1,016
| -3% | -$48.5K |
|
|
CBIO
3105
Crescent Biopharma
CBIO
$626M
| $2.04M | ﹤0.01% |
1,254
+1,251
| +41,700% | +$2.6M |
|
3106
CALL
JetBlue
JBLU
$2.29B
| $2.03M | ﹤0.01% |
+100,000
| New | +$2.13M |
|
3107
Nuveen California AMT-Free Quality Municipal Income Fund
NKX
$657M
| $2.03M | ﹤0.01% |
149,916
+2,073
| +1% | +$29.7K |
|
|
GGN
3108
GAMCO Global Gold, Natural Resources & Income Trust
GGN
$819M
| $2.03M | ﹤0.01% |
414,901
+118,454
| +40% | +$608K |
|
|
MIN
3109
Aberdeen Intermediate Income Fund
MIN
$278M
| $2.03M | ﹤0.01% |
516,029
-14,096
| -3% | -$56.2K |
|
|
SODA
3110
DELISTED
SodaStream International Ltd
SODA
| $2.03M | ﹤0.01% |
22,085
+4,979
| +29% | +$404K |
|
3111
Fidelity Limited Term Bond ETF
FLTB
$415M
| $2.03M | ﹤0.01% |
+40,932
| New | +$2.03M |
|
3112
CALL
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
$23.2B
| $2.03M | ﹤0.01% |
40,000
-712,200
| -95% | -$37.1M |
|
3113
CALL
International Paper
IP
$22B
| $2.02M | ﹤0.01% |
40,022
-112,253
| -74% | -$6.24M |
|
3114
Cavco Industries
CVCO
$4.55B
| $2.02M | ﹤0.01% |
11,635
-1,650
| -12% | -$273K |
|
3115
Liberty Broadband Class A
LBRDA
$5.16B
| $2.02M | ﹤0.01% |
23,805
-1,236
| -5% | -$111K |
|
3116
Orion
OEC
$409M
| $2.02M | ﹤0.01% |
74,514
+52,018
| +231% | +$1.45M |
|
|
CBA
3117
DELISTED
ClearBridge American Energy MLP
CBA
| $2.02M | ﹤0.01% |
296,475
-21,648
| -7% | -$179K |
|
|
DSM
3118
BNY Mellon Strategic Municipal Bond Fund
DSM
$293M
| $2.02M | ﹤0.01% |
265,210
+24,394
| +10% | +$193K |
|
3119
CALL
Wolfspeed
WOLF
$1.71B
| $2.02M | ﹤0.01% |
+50,000
| New | +$1.88M |
|
3120
Rayonier
RYN
$6.55B
| $2.01M | ﹤0.01% |
63,104
-21,442
| -25% | -$652K |
|
|
PTR
3121
DELISTED
PETROCHINA COMPANY LIMITED ADS (REP 100 H SHARES)
PTR
| $2.01M | ﹤0.01% |
28,879
-5,504
| -16% | -$397K |
|
|
UNT
3122
DELISTED
UNIT Corporation
UNT
| $2.01M | ﹤0.01% |
101,804
+27,316
| +37% | +$595K |
|
|
MDP
3123
DELISTED
Meredith Corporation
MDP
| $2.01M | ﹤0.01% |
37,308
-1,800
| -5% | -$107K |
|
3124
iShares Morningstar Small-Cap ETF
ISCB
$292M
| $2.01M | ﹤0.01% |
47,528
-27,452
| -37% | -$1.19M |
|
|
VRN
3125
DELISTED
Veren
VRN
| $2M | ﹤0.01% |
294,831
+11,865
| +4% | +$90K |
|
Similar funds
UBS Group's Q1 2018 Portfolio in Review
As of Q1 2018, UBS Group held 8,641 positions worth $232B, down 4.8% from $243B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
UBS Group withdrew a net $8.61B in Q1 2018, closing 751 positions and reducing 3,579 holdings. Its most notable exit was CalAtlantic Group, Inc., an estimated $60.8M position sold in full.
By sector, the portfolio is most concentrated in Technology at 8.1% of assets, up from 7.2% a quarter earlier, followed by Financials and Healthcare.
Against the trend, UBS Group opened a new position in Nutrien worth $56.3M.
- UBS Group's largest Q1 2018 buy was Nutrien: 1,191,668 shares worth $56.3M.
- UBS Group added most to Comcast in Q1 2018, an estimated $488M increase.
- UBS Group's biggest Q1 2018 reduction was UBS Group, cutting an estimated $755M.
- UBS Group fully exited CalAtlantic Group, Inc. in Q1 2018, selling an estimated $60.8M.
- UBS Group's ten largest holdings make up 15% of its $232B portfolio in Q1 2018.
- UBS Group opened 725 new positions and closed 751 in Q1 2018.
- UBS Group's portfolio value fell 4.8% quarter-over-quarter to $232B.
Based on UBS Group's 13F filing for Q1 2018, filed 15 May 2018.